Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Results of the CHAPTER-1 Open- Label Extension Study

被引:0
|
作者
Riedl, Marc [1 ]
Anderson, John [2 ]
Arcoleo, Francesco [3 ]
Cancian, Mauro [4 ]
Chapdelaine, Hugo [5 ]
Conlon, Niall [6 ,7 ]
Eren, Efrem [8 ]
Gompels, Mark [9 ]
Grigoriadou, Sofia [10 ]
Guarino, Maria [11 ]
Gurugam, Padmalal [12 ]
Kinaciyan, Tamar [13 ]
Magerl, Markus [14 ,15 ]
Manning, Michael [16 ]
Stobiecki, Marcin [17 ]
Tarzi, Michael [18 ]
Valerieva, Anna [19 ]
Wedner, H. James [20 ]
Yang, William [21 ]
Zanichelli, Andrea [22 ,23 ]
Crabbe, Rafael
Mulders, Susan
Levy, Jonathan [24 ]
Freudensprung, Ulrich [25 ]
Katbeh, Umar [25 ]
Knolle, Jochen [26 ]
Lesage, Anne [27 ]
Lu, Peng [24 ]
Aygoeren-Puersuen, Emel
机构
[1] Univ Calif La Jolla, La Jolla, CA USA
[2] AllerVie Hlth, Clin Res Ctr Alabama, Birmingham, AL USA
[3] UOC Patol Clin & Immunol, AOR Villa Sofia Cervello, Palermo, Italy
[4] Univ Hosp Padua, Padua, Italy
[5] UQAC, Chicoutimi, PQ, Canada
[6] St Jamess Hosp & Trinity Coll, Dublin, Ireland
[7] Wellcome Trust CRF, Trinity Coll, Dublin, Ireland
[8] Univ Hosp Southampton NHS Fdn Trust, Southampton, England
[9] North Bristol NHS Trust, Bristol, England
[10] Barts Hlth NHS Trust, London, England
[11] Osped Civitanova Marche, Civitanova Marche, Italy
[12] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[13] Med Univ Vienna, Vienna, Austria
[14] Charite, Berlin, Germany
[15] Fraunhofer ITMP Immunol & Allergol, Berlin, Germany
[16] Allergy Asthma & Immunol Associates Ltd, Scottsdale, AZ USA
[17] Jagiellonian Univ Med Coll, Krakow, Poland
[18] Univ Hosp Sussex NHS Fdn Trust, Brighton, England
[19] Med Univ Sofia, Dept Allergol, Sofia, Bulgaria
[20] Washington Univ, Sch Med, Div Allergy & Immunol, St Louis, MO USA
[21] Ottawa Allergy Res Corp, Ottawa, ON, Canada
[22] Univ Milan, Milan, Italy
[23] IRCCS, Policlin San Donato, Milan, Italy
[24] Pharvaris Inc, Lexington, MA USA
[25] Pharvaris GmbH, Zug, Switzerland
[26] JCK Consult, Frankfurt, Germany
[27] GrayMatters Consulting, Schilde, Belgium
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
600
引用
收藏
页码:AB194 / AB194
页数:1
相关论文
共 50 条
  • [21] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Banerji, A.
    Hao, J.
    Yu, M.
    Bernstein, J.
    Johnston, D.
    Riedl, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S21 - S21
  • [22] Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study
    Craig, Timothy J.
    Levy, Donald S.
    Reshef, Avner
    Lumry, William R.
    Martinez-Saguer, Inmaculada
    Jacobs, Joshua S.
    Yang, William H.
    Ritchie, Bruce
    Aygoeren-Puersuen, Emel
    Keith, Paul K.
    Busse, Paula
    Feuersenger, Henrike
    Bica, Mihai Alexandru
    Jacobs, Iris
    Pragst, Ingo
    Magerl, Markus
    LANCET HAEMATOLOGY, 2024, 11 (06): : e436 - e447
  • [23] Garadacimab for hereditary angioedema prophylaxis: long term efficacy and safety from the Phase 3 VANGUARD trial and first interim analysis of the open-label extension trial
    Reshef, A.
    Magerl, M.
    Saguer, I. Martinez
    Bernstein, J. A.
    Farkas, H.
    Yang, W. H.
    Jacobs, J. S.
    Li, P. Hei
    Lumry, W. R.
    Aygoeren-Puersuen, E.
    Ohsawa, I.
    Katelaris, C.
    Longhurst, H.
    Hakl, R.
    Guilarte, M.
    Stroes, E. S. G.
    Feuersenger, H.
    Bica, M. A.
    Jacobs, I.
    Craig, T. J.
    ALLERGOLOGIE, 2023, 46 (08) : 561 - 562
  • [24] A new oral kallikrein inhibitor for long-term prophylaxis of hereditary angioedema
    Dona, Inmaculada
    Torres, Maria Jose
    ALLERGY, 2021, 76 (06) : 1619 - 1620
  • [25] Long-term safety and effectiveness of berotralstat for hereditary angioedema: The open-label APeX-S study
    Farkas, Henriette
    Stobiecki, Marcin
    Peter, Jonny
    Kinaciyan, Tamar
    Maurer, Marcus
    Aygoren-Pursun, Emel
    Kiani-Alikhan, Sorena
    Wu, Adrian
    Reshef, Avner
    Bygum, Anette
    Fain, Olivier
    Hagin, David
    Huissoon, Aarnoud
    Jesenak, Milos
    Lindsay, Karen
    Panovska, Vesna Grivcheva
    Steiner, Urs C.
    Zubrinich, Celia
    Best, Jessica M.
    Cornpropst, Melanie
    Dix, Daniel
    Dobo, Sylvia M.
    Iocca, Heather A.
    Desai, Bhavisha
    Murray, Sharon C.
    Nagy, Eniko
    Sheridan, William P.
    CLINICAL AND TRANSLATIONAL ALLERGY, 2021, 11 (04)
  • [26] Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
    Vermeire, Severine
    Chiorean, Michael
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Klassen, Preston
    Naik, Snehal U.
    Cabell, Christopher H.
    Sandborn, William J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (06) : 950 - 959
  • [27] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
    Gevaert, Philippe
    Saenz, Rebecca
    Corren, Jonathan
    Han, Joseph K.
    Mullol, Joaquim
    Lee, Stella E.
    Ow, Randall A.
    Zhao, Rui
    Howard, Monet
    Wong, Kit
    Islam, Lutaf
    Ligueros-Saylan, Monica
    Omachi, Theodore A.
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +
  • [28] Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
    Levy, Donald S.
    Farkas, Henriette
    Riedl, Marc A.
    Hsu, Florence Ida
    Brooks, Joel P.
    Cicardi, Marco
    Feuersenger, Henrike
    Pragst, Ingo
    Reshef, Avner
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2020, 16 (01)
  • [29] Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
    Donald S. Levy
    Henriette Farkas
    Marc A. Riedl
    Florence Ida Hsu
    Joel P. Brooks
    Marco Cicardi
    Henrike Feuersenger
    Ingo Pragst
    Avner Reshef
    Allergy, Asthma & Clinical Immunology, 16
  • [30] Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study
    Chiorean, Michael
    Vermeire, Severine
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Cabell, Chris H.
    Naik, Snehal U.
    Klassen, Preston
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S445 - S446